Zobrazeno 1 - 10
of 44
pro vyhledávání: '"David J, Pennisi"'
Autor:
Anastassia Demeshko, David J. Pennisi, Sushil Narayan, Stacy W. Gray, Matthew A. Brown, Aideen M. McInerney-Leo
Publikováno v:
Journal of Translational Medicine, Vol 18, Iss 1, Pp 1-7 (2020)
Abstract Background Clinical whole exome sequencing was introduced in an Australian centre in 2017, as an alternative to Sanger sequencing. We aimed to identify predictors of cancer physicians’ somatic mutation test ordering behaviour. Methods A va
Externí odkaz:
https://doaj.org/article/0ffd9d5237054713b4db2ff0eef5b33b
Autor:
Brooke W. Purdue, Melissa E. Reichelt, David J. Pennisi, Enzo R. Porrello, Nicola J. Smith, Giovanna Gambarotta, Zhen Wang, Hsiu-Wen Chan, Shannon L. O'Brien, Walter G. Thomas, Tamara M. Paravicini
Publikováno v:
Journal of Cellular Physiology. 236:8160-8170
Epidermal growth factor (EGF) receptors (ErbB1-ErbB4) promote cardiac development and growth, although the specific EGF ligands and receptor isoforms involved in growth/repair versus pathology remain undefined. We challenged ventricular cardiomyocyte
Autor:
Stacy W. Gray, Anastassia Demeshko, Sushil Narayan, David J. Pennisi, Aideen M. McInerney-Leo, Matthew A. Brown
Publikováno v:
Journal of Translational Medicine, Vol 18, Iss 1, Pp 1-7 (2020)
Journal of Translational Medicine
Journal of Translational Medicine
Background Clinical whole exome sequencing was introduced in an Australian centre in 2017, as an alternative to Sanger sequencing. We aimed to identify predictors of cancer physicians’ somatic mutation test ordering behaviour. Methods A validated i
Autor:
Jason I Hockings, Catherine Luxford, Amanda J Seabrook, G. I. Hockings, Aideen M. McInerney-Leo, Trisha Dwight, Sofia B Velosa, David J. Pennisi, Edward Kim, Judy Kirk, Roderick J. Clifton-Bligh, Nicholas G Hockings, Ozgur Mete, Anthony J. Gill, Jessica Harris, Emma L. Duncan, Paul Leo, Matthew A. Brown, Amanda Love, Mhairi Marshall
Publikováno v:
The Journal of clinical endocrinology and metabolism. 106(4)
Context Pathogenic germline MAX variants are associated with pheochromocytoma and paraganglioma (PPGL), pituitary neuroendocrine tumors and, possibly, other endocrine and nonendocrine tumors. Objective To report 2 families with germline MAX variants,
Autor:
Xiaoxia Song, Matthew A. Brown, Paul Leo, Gethin P. Thomas, Katelin Haynes, Zhixiu Li, David J. Pennisi, Tony J. Kenna, Lisa Anderson
Publikováno v:
Genes & Immunity. 18:135-143
Ankylosing spondylitis (AS) is a common immune-mediated arthropathy primarily affecting the spine and pelvis. Most AS patients have subclinical intestinal inflammation, suggesting the gut microbiome and the immune response play a role in pathogenesis
Autor:
Rahul Ladwa, James Monkman, Paul Leo, David J. Pennisi, Sanjay Dutta, Arutha Kulasinghe, Kenneth J. O'Byrne, Kate Roberts
Publikováno v:
Lung Cancer. 156:S1
Autor:
Zhixiu Li, David J. Pennisi, Ying Ji, Matthew A. Brown, Pamela A. McCombe, Paul Leo, Stefan Blum
Publikováno v:
Journal of neuroimmunology. 323
Guillain-Barre syndrome (GBS) is considered to have an immune-mediated basis, but the genetic contribution to GBS is unclear. We conducted a GWAS involving 215 GBS patients and 1,105 healthy controls. No significant associations of individual SNPs or
Autor:
Oliver H. Tam, David J. Pennisi, Lorine Wilkinson, Victor L. Wan, Melissa H. Little, Fatima Wazin, Frank J. Lovicu
Publikováno v:
Experimental eye research. 170
The development and growth of the vertebrate ocular lens is dependent on the regulated proliferation of an anterior monolayer of epithelial cells, and their subsequent differentiation into elongate fiber cells. The growth factor rich ocular media tha
Autor:
Jonathan Ellis, X B Wang, Zhixiu Li, David J. Pennisi, K Hollis, Tony J. Kenna, Linda A. Bradbury, Matthew A. Brown, Xiaoxia Song, Jyotsna Batra
Publikováno v:
Genes and immunity. 18(3)
Tumor necrosis factor-α (TNF-α) inhibitors are highly effective in suppressing inflammation in ankylosing spondylitis (AS) patients, and operate by suppression of TFN-α and downstream immunological pathways. To determine the mechanisms of action o
Publikováno v:
The Journal of Pathology. 229:685-696
Crim1 is a transmembrane protein that regulates the bioavailability of growth factors such as VEGFA. Crim1(KST264)(/)(KST264) hypomorphic mice develop renal disease characterized by glomerular cysts and loss of endothelial integrity, progressing to p